GT200400183A - DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS - Google Patents

DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS

Info

Publication number
GT200400183A
GT200400183A GT200400183A GT200400183A GT200400183A GT 200400183 A GT200400183 A GT 200400183A GT 200400183 A GT200400183 A GT 200400183A GT 200400183 A GT200400183 A GT 200400183A GT 200400183 A GT200400183 A GT 200400183A
Authority
GT
Guatemala
Prior art keywords
azithromycin
dosage forms
side effects
reduced side
effective amount
Prior art date
Application number
GT200400183A
Other languages
Spanish (es)
Inventor
Timothy Arthur Hagen
Scott Max Herbig
Julian Belknap
Avinash Govind
Leah Elizabeth Appel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200400183A publication Critical patent/GT200400183A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCIÒN SE REFIERE A UNA FORMA DE DOSIFICACIÒN ORAL QUE COMPRENDE AZITROMICINA Y UNA CANTIDAD EFICAZ DE UN AGENTE ALCALINIZANTE. PREFERIBLEMENTE, DICHA FORMA DE DOSIFICACIÒN ORAL COMPRENDE UNA CANTIDAD EFICAZ DE UN AGENTE ALCALINIZANTE Y UN MULTIPARTICULADO DE AZITROMICINA.THE PRESENT INVENTION REFERS TO AN ORAL DOSAGE FORM THAT INCLUDES AZITHROMYCIN AND AN EFFECTIVE AMOUNT OF AN ALKALINIZING AGENT. PREFERIBLY, SUCH ORAL DOSAGE FORM INCLUDES AN EFFECTIVE AMOUNT OF AN ALKALINIZING AGENT AND A MULTIPARTICULATE OF AZITHROMYCIN.

GT200400183A 2003-12-04 2004-09-16 DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS GT200400183A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52708403P 2003-12-04 2003-12-04

Publications (1)

Publication Number Publication Date
GT200400183A true GT200400183A (en) 2005-10-24

Family

ID=34699855

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200400183A GT200400183A (en) 2003-12-04 2004-09-16 DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS

Country Status (8)

Country Link
CN (1) CN1697648B (en)
AP (1) AP2218A (en)
AU (1) AU2004216676B2 (en)
EC (1) ECSP045351A (en)
GT (1) GT200400183A (en)
TN (1) TNSN05319A1 (en)
UA (1) UA78793C2 (en)
ZA (1) ZA200408075B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200805793B (en) * 2005-12-22 2009-11-25 Otsuka Pharma Co Ltd Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol
CN103054813A (en) * 2012-12-31 2013-04-24 广东先强药业有限公司 Azithromycin oral sustained-release dry suspension and preparation method thereof
CN104177457A (en) * 2013-05-23 2014-12-03 长春海悦药业有限公司 Azithromycin drug raw material, and preparation and application thereof
CN107427494A (en) * 2015-03-10 2017-12-01 卢莫斯制药公司 The micro- supensoid agent of circular muscle acid
CA3051914A1 (en) * 2017-02-02 2018-08-09 Mcmaster University Bicarbonate as a potentiator for antimicrobial agents
CN114213484A (en) * 2021-12-21 2022-03-22 河北远征药业有限公司 Tildipirosin 1, 2-propylene glycol solvent compound and preparation method thereof
CN115212173A (en) * 2022-07-11 2022-10-21 上海现代药物制剂工程研究中心有限公司 Ambroxol hydrochloride spherical sustained-release particles, preparation method and application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (en) * 1992-07-30 1996-03-01 Pfizer
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
CN1123279A (en) * 1995-06-15 1996-05-29 沈家祥 Azithmycin water-soluble salt, injection thereof and their usage
NZ534234A (en) * 2002-02-01 2007-05-31 Pfizer Prod Inc Dry granulated formulations of non-dihydrate form of azithromycin

Also Published As

Publication number Publication date
CN1697648B (en) 2010-06-23
AU2004216676A1 (en) 2005-06-23
AU2004216676B2 (en) 2011-06-16
ZA200408075B (en) 2007-01-31
AP2004003145A0 (en) 2004-09-30
ECSP045351A (en) 2005-01-28
TNSN05319A1 (en) 2007-07-10
UA78793C2 (en) 2007-04-25
CN1697648A (en) 2005-11-16
AP2218A (en) 2011-04-20

Similar Documents

Publication Publication Date Title
UY28509A1 (en) DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS
DOP2019000185A (en) A SOLID PHARMACEUTICAL DOSAGE FORMULATION
CL2004000927A1 (en) TRANSDERMAL DOSAGE FORM THAT INCLUDES AN ACTIVE AGENT, A NEXT SURFACE AND A DISTAL SURFACE.
JP2004210767A5 (en)
RS50660B (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
HN2002000142A (en) SHAMPOOS WITH BEHENYL ALCOHOL
ES2539945T3 (en) Oral formulations of opioid agonists resistant to improper manipulations
BR0304291B1 (en) sanitary napkin.
ECSP055888A (en) DERIVATIVES OF ARIL-QUINAZOLIN / ARIL-2-AMINO-FENIL METANONA THAT PROMOTE THE RELEASE OF PARTIROID HORMONE.
ECSP078057A (en) FORMULATIONS OF CONJUGATED ESTROGENS AND BAZEDOXIFEN
TW200733954A (en) Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
GT200400183A (en) DOSAGE FORMS OF AZITHROMYCIN WITH REDUCED SIDE EFFECTS
DK1713438T3 (en) Medical soap
NO20040857L (en) New oral prolonged release dosage form.
EA200600066A1 (en) Tamsulozine-containing core coated with polyvinylpyrrolidone or polyvinyl acetate
NO20040966D0 (en) Oral vaccines.
GT200600403A (en) PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS
GEP20084546B (en) Novel association consisting of an anti-atherothrombotic agent and of platelet antiaggregating agent
NO20031239L (en) 1-amino-alkylcyclohexanes as trypanocidal agents
MXPA03001857A (en) MEDICINAL COMPOSITIONS.
AR027152A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COGNITIVE CEREBROVASCULAR DISEASE.
UY27083A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COGNOSTIC CEREBROVASCULAR DISEASE
RU2000116332A (en) ANThelmintic
ES1050190Y (en) ELECTRICAL GENERATOR IN THE FORM OF A BALANCE UNBALANCED BY A BALL THAT TRAVELS A CHANNEL ABOVE THE BALANCE.
BR0102216B1 (en) Improvements to the integrated valve discharge valve.